Katherine Eade
Director/Board Member chez HARVARD BIOSCIENCE, INC.
Fortune : 962 459 $ au 31/03/2024
Profil
Katherine A.
Eade is an Independent Director at Harvard Bioscience, Inc. She previously worked as the Director-M&A Law at Corning, Inc. from 2009 to 2018.
She also served as an Independent Director at Vaxxinity, Inc. in 2023.
In addition, Katherine was the Deputy General Counsel at La-Z-Boy, Inc. from 2018 to 2019 and the Vice President-Strategic Commercial Affairs at Align Technology, Inc. from 2019 to 2020.
Prior to that, she worked as an Attorney at Cleary Gottlieb Steen & Hamilton LLP from 2001 to 2009.
Katherine also served as the General Counsel at Checkmate Pharmaceuticals, Inc. from 2020 to 2022.
She has a background in law, having obtained her undergraduate degree from Cornell University and her graduate degree from Harvard Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HARVARD BIOSCIENCE, INC.
0,52% | 22/05/2023 | 226 995 ( 0,52% ) | 962 459 $ | 31/03/2024 |
Postes actifs de Katherine Eade
| Sociétés | Poste | Début |
|---|---|---|
| HARVARD BIOSCIENCE, INC. | Director/Board Member | 24/10/2017 |
Anciens postes connus de Katherine Eade
| Sociétés | Poste | Fin |
|---|---|---|
| VAXXINITY, INC. | Director/Board Member | 30/11/2023 |
| CHECKMATE PHARMACEUTICALS, INC. | General Counsel | 01/05/2022 |
| ALIGN TECHNOLOGY, INC. | Corporate Officer/Principal | 01/07/2020 |
| LA-Z-BOY INCORPORATED | Corporate Officer/Principal | 01/01/2019 |
| CORNING INCORPORATED | Corporate Officer/Principal | 01/01/2018 |
Formation de Katherine Eade
| Cornell University | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| CORNING INCORPORATED | Electronic Technology |
| LA-Z-BOY INCORPORATED | Consumer Durables |
| HARVARD BIOSCIENCE, INC. | Health Technology |
| ALIGN TECHNOLOGY, INC. | Health Technology |
| STANDARD BIOTOOLS INC. | Health Technology |
| VAXXINITY, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Cleary Gottlieb Steen & Hamilton LLP
 Cleary Gottlieb Steen & Hamilton LLP Miscellaneous Commercial ServicesCommercial Services Cleary Gottlieb Steen & Hamilton LLP is an international law firm that provides legal services to clients. The company serves multinational corporations, international financial institutions, sovereign governments and its agencies and domestic corporations and financial institutions. The company was founded by George Cleary, Leo Gottlieb, Henry Friendly, Mel Steen, Hugh Cox, Fowler Hamilton and George Ball in 1946 and it is headquartered in New York, NY. | Commercial Services |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
